Undersøgelsen viste gavnlig effekt af memantinbehandlingen sammenlignet med placebo over en behandlingsperiode på 6 måneder (vurderet ud fra analyse af observerede patienter til CIBIC- plus (Clinician´s interview based impression of change): p=0, 025, samt ADCS - ADLsev (Alzheimer´s disease cooperative study’ s activities of daily living): p=0, 003 og SIB (Severe impairment battery): p=0, 002).
22 nei confronti del placebo a 6 mesi (analisi dei casi osservati Clinician’ s Interview Based Impression of Change (CIBIC-plus): p=0,025; Alzheimer’ s Disease Cooperative Study – Activities of Daily Living (ADCS-ADLsev): p=0,003; Severe Impairment Battery (SIB): p=0,002).